skip to content
Primary navigation

Drug Formulary Committee

The Drug Formulary Committee uses an open, transparent process to review and recommend the drugs covered by Medicaid and MinnesotaCare through the uniform preferred drug list and determine which of those drugs requires prior authorization, or an approval before payment, to ensure medications are medically necessary for specific patients and appropriate for their situation.

Drug Formulary Committee meetings are open to the public. Public comments may be given during the open forum at the beginning of the meeting or submitted in writing up to 15 days after the committee makes recommendations.

Committee members include four physicians, at least three pharmacists, a consumer representative and knowledgeable health care professionals who all submit a conflict-of-interest form DHS-3785 (PDF). The Department of Human Services (DHS) provides the committee with data and information about the impact of its decision on the quality and cost of patient care. 

Appointing authority: Commissioner of Human Services 
Compensation: $100 per member per meeting plus mileage   
(Minnesota Statutes 256B.0625, subd. 13)

Email Updates
Sign up for Drug Formulary Committee news and upcoming meeting information below.
back to top